Find out more
The President of the Faculty of Pharmaceutical Medicine, Dr Flic Gabbay, is planning to hold two meetings in the USA to make contact with FPM members who will be attending the following:
- BIO International Convention in San Diego, CA June 13-16 2022
- DIA 2022 Annual Meeting in Chicago, June 19-23 2022.
Dr Gabbay will be accompanied by Dr Viraj Rajadhyaksha, Chair of FPM Global and Dr Jeymi Tambiah, a member of FPM Global.
The aim of the meetings will be to provide a forum for our members who live and/or work in the USA to meet, network and discuss the following:
- The newly formed FPM Global Forum, its plans and how US members may get involved
- Understand how FPM may provide better support to its members who work in the USA
- The key relationships with US and International based organisations and what FPM could add in terms of value
We are delighted that the meeting in San Diego will be hosted by Dr Tambiah’s organisation, Biosplice Therapeutics between 10:00 to 13:00 hours (PT) on Monday 13 June 2022 with lunch available from 12:00 hours. Details about the meeting in Chicago will follow shortly.
If you wish for any further details, please contact Marcia Philbin, firstname.lastname@example.org
Dr Flic Gabbay
Dr Gabbay spent 11 years in big pharma before founding a CRO sold to PPD, then was CEO of two small biotechs and subsequently founded TranScrip, a leading pharma consultancy, in 2008.
She chaired the RCP London working party that set up the Faculty of Pharmaceutical Medicine under the three UK Colleges of Physicians (1989) where she spent 9 years as Academic Registrar while continuing her pharmaceutical career. Her contributions to standards in R&D go well beyond the Faculty working on numerous global drug development guidelines for rheumatology, epilepsy, ethics, antibiotics, antivirals, respiratory medicine and the pharmaceutical panel for the NHS-HTA, the forerunner of UK HTA.
Dr Gabbay joins a small group of other pharmaceutical medicine Fellows of the Academy of Medical Sciences which highlights the growing recognition of the specialty of pharmaceutical medicine and the vital role it plays in innovative research and in supporting the health of patients.
Dr Viraj Rajadhyaksha MD, MS, DBM
Dr Viraj Rajadhyaksha has an MS in Pharmaceutical Medicine from University of Surrey, Guildford, UK. MD from Seth GS Medical College and King Edward VII Memorial Hospital, University of Mumbai (2002). Viraj is currently working as Area Medical Director Middle East and Africa AstraZeneca driving medical strategy across all therapy areas in the Area as well as develop medical talents. Previously he was the International (Emerging markets) Oncology Medical Director preceded by Medical Director- Malaysia, Singapore, Brunei across all therapy areas. Before that, Viraj led the Diabetes portfolio in AstraZeneca for Asia. Viraj has 17 years of experience as a pharmaceutical physician across Emerging countries in primary and leadership positions.
Dr Jeymi Tambiah BSc (Hons) (Med. Sci.), MBChB, FRCS (Eng, Edin), M.S.
Dr Tambiah is Senior Vice President, Medical Affairs, at Biosplice Therapeutics Inc., a San Diego-based biotech focused on drug development for treatment of Wnt pathway-related diseases. Joining the pharmaceutical industry in 2008, he has led medical teams in the UK and US, developing expertise in medical affairs, clinical development, translational medicine, and health outcomes. Prior to commencing his industry career, he qualified in medicine at St. Andrews and Manchester Universities, was a cardiothoracic specialist registrar at Guy’s and St. Thomas’ Hospitals and gained a medical doctorate degree in vascular immunology at Imperial College London.